Indefinite Delivery Contract HHSO100201600007I

The Department of Health and Human Services (HHS) Office of the Assistant Secretary for Preparedness and Response (ASPR) awarded a $505.3 million single-award Indefinite Delivery Contract (IDC) to Alvogen, Inc. to deliver the antiviral drug oseltamivir phosphate to the Strategic National Stockpile. This IDC, which has an ultimate completion date of February 6, 2025, allows ASPR to issue task orders to Alvogen for the procurement and distribution of this essential medical countermeasure to...

This indefinite delivery contract, awarded by the Office of the Assistant Secretary for Preparedness and Response (ASPR), a civilian agency within the U.S. Department of Health and Human Services (HHS), has a ceiling value of $4,687,707,199. The purpose is to provide medical countermeasures such as vaccines and adjuvants for pandemic preparedness and response or in response to a public health emergency designated by HHS. The prime contractor is Glaxosmithkline, LLC, a pharmaceutical company that...

This indefinite delivery contract (IDC) was awarded by the Centers for Disease Control and Prevention (CDC) Office of Acquisition Services, a civilian federal agency, to MedImmune, LLC, a for-profit organization. The single-award IDC has a ceiling value of $373,407,823 and a period of performance ending on February 28, 2011. The contract aims to procure flu vaccine products and related services as part of the CDC's Vaccine for Children (VFC) program in support of the 2010 flu season. The...

This indefinite delivery contract, awarded by the Defense Logistics Agency Troop Support Medical, provides for the delivery of various medical products and treatments to the U.S. government. The prime contractor is Meridian Medical Technologies, LLC, a wholly-owned subsidiary of Pfizer Inc. The contract, valued at up to $597 million, has a period of performance from January 1, 2013 to December 31, 2014. It does not utilize any set-aside designations. Meridian has been awarded multiple delivery...

The Department of Health and Human Services (HHS) Office of the Assistant Secretary for Preparedness and Response (ASPR) awarded a $5.87 billion Indefinite Delivery Indefinite Quantity (IDIQ) contract to Sanofi Pasteur Inc., a foreign-owned, for-profit pharmaceutical manufacturer, to supply medical countermeasures (MCMs) such as vaccines and adjuvants for pandemic preparedness and response. This IDIQ contract serves as the vehicle for issuing multiple delivery orders to Sanofi Pasteur over a...

This indefinite delivery contract (IDC) was awarded by the Office of the Assistant Secretary for Preparedness and Response (ASPR), a civilian federal agency, to Glaxosmithkline, LLC, a pharmaceutical company, to provide a portfolio of new antibacterial drugs for hospital and biothreat pathogens. The single-award IDC has a ceiling value of $255,851,502.87 and a period of performance through September 30, 2029. The contract aims to procure a range of pharmaceutical products and services from...

The federal contract IDV award is a $4.9 billion Federal Supply Schedule contract between the Department of Veterans Affairs and Genentech USA, Inc., a foreign-owned, for-profit pharmaceutical manufacturer. The contract covers a wide range of drugs, pharmaceuticals, and hematology-related products for the VA and other federal agencies. Under this IDV, Genentech has received several delivery orders from the Office of the Assistant Secretary for Preparedness and Response (ASPR), a civilian...

The Department of Health and Human Services (HHS) Office of the Assistant Secretary for Preparedness and Response (ASPR) awarded an indefinite delivery contract to Glaxosmithkline, LLC, a foreign-owned pharmaceutical company, to provide a range of pharmaceutical products and services under the Pandemic Influenza Preparedness and Response 2016-2021 program. The $2.11 billion multiple award contract has no set-aside designation and supports government efforts for disease prevention,...

The Department of Health and Human Services (HHS) Office of the Assistant Secretary for Preparedness and Response (ASPR) awarded an Indefinite Delivery Contract (IDC) to Sanofi Pasteur Inc., a foreign-owned, for-profit manufacturer of vaccines and pharmaceuticals. The 5-year IDC, valued up to $5.87 billion, is for the provision of medical countermeasures to address emerging public health threats, including pandemic influenza. Under this contract, Sanofi Pasteur has received multiple firm...

This indefinite delivery contract was awarded by the Department of Veterans Affairs (VA) National Acquisition Center to AstraZeneca Pharmaceuticals LP, a foreign-owned, for-profit pharmaceutical manufacturer. The contract, valued at $377,812,500, is for the supply of anti-interleukin monoclonal antibody products, specifically benralizumab, for use by the VA, Department of Defense (DoD), Bureau of Prisons (BOP), and Indian Health Service (IHS). The contract has a base period of one year from...